Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Aurinia Pharmaceuticals Inc. Common Shares, no par value (AUPH).
- Disclosed ownership: 7.3%.
- Date of event: 28 Feb 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 7.3% ownership in Aurinia Pharmaceuticals Inc. Common Shares, no par value (AUPH) on 28 Feb 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 7.3% | 10,029,500 | 0 | 10,029,500 | /s/ Kevin Tang | Manager | 0001232621 |
| KEVIN TANG | 7.3% | 10,029,500 | 0 | 10,029,500 | /s/ Kevin Tang | Self | 0001178579 |
| TANG CAPITAL PARTNERS, LP | 3.7% | 5,140,591 | 0 | 5,140,591 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0001191935 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.2% | 4,388,909 | 0 | 4,388,909 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.4% | 500,000 | 0 | 500,000 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |